Precision pulls IPO, merges with Oracle to go public; withdrawn
Precision Therapeutics Inc. (personalized cancer diagnostics) has decided to withdraw its IPO filed earlier this year, and instead go public via a merger with Oracle Healthcare Acquisition (a special purpose acquisition company).
- In Vitro Diagnostics
In Vitro Diagnostics
- Chemistry, Immunoassay
- Includes Contract
- Reverse Acquisition
- Special Purpose Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.